Full Text Full Text (PDF) Supplemental Figure Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Paddock, S. Articles by McMahon, F. J. Search for Related Content PubMed Citation Articles by Paddock, S. Articles by McMahon, F. J. Depression Antidepressants Related Articles

Association of GRIK4 With Outcome of Antidepressant Treatment in the STAR*D Cohort

OBJECTIVE: An initial pharmacogenetic study of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) clinical trial reported an association between genetic variation in the HTR2A gene and outcome of citalopram treatment. By design, the study analyzed only those markers that showed reproducible association in the first wave of genotypes (comprising 1,297 patients) in the complete cohort of patients. The purpose of the present study was to utilize a second wave of genotype results, for a more powerful analysis, in the complete cohort of patients with available deoxyribonucleic acid (DNA) samples. METHOD: The authors tested the association between treatment response and 768 markers that were genotyped in the full set of 1,816 eligible patients from the STAR*D cohort. In order to control for multiple testing, the subjects were divided into two study groups: discovery and replication. RESULTS: In addition to the previously identified marker in the HTR2A gene, a new marker (rs1954787) in the GRIK4 gene, which codes for the kainic acid-type glutamate receptor KA1, was observed. The effect size of the GRIK4 marker alone was modest, but homozygote carriers of the treatment-response-associated marker alleles of both the GRIK4 and HTR2A genes were 23% less likely to experience nonresponse to treatment relative to participants who did not carry any of these marker alleles. CONCLUSIONS: The findings demonstrate that genetic variation in a kainic acid-type glutamate receptor is reproducibly associated with response to the antidepressant citalopram. This finding suggests that the glutamate system plays an important role in modulating response to selective serotonin reuptake inhibitors (SSRIs).

Related Articles:

Keeping Our Depressed Patients in the Right Treatment Long Enough for Them to Get Better: Some Hopeful Findings

Mary Anne Badaracco
Am J Psychiatry 2007 164: 1136-1139. [Full Text] [PDF]

This article has been cited by other articles:

				G. Laje, R. H. Perlis, A. J. Rush, and F. J. McMahon Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results Psychiatr Serv, November 1, 2009; 60(11): 1446 - 1457. [Abstract] [Full Text] [PDF]

				R. Machado-Vieira, H. K. Manji, and C. A. Zarate The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders Neuroscientist, October 1, 2009; 15(5): 525 - 539. [Abstract] [PDF]

				M. Ising, S. Lucae, E. B. Binder, T. Bettecken, M. Uhr, S. Ripke, M. A. Kohli, J. M. Hennings, S. Horstmann, S. Kloiber, et al. A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression Arch Gen Psychiatry, September 1, 2009; 66(9): 966 - 975. [Abstract] [Full Text] [PDF]

				R. M. Carney and K. E. Freedland Treatment-Resistant Depression and Mortality After Acute Coronary Syndrome Am J Psychiatry, April 1, 2009; 166(4): 410 - 417. [Abstract] [Full Text] [PDF]

				P. R. Muskin The Teaching of Psychiatry to Non-Psychiatrists: The Patient as a Person Acad Psychiatry, November 1, 2008; 32(6): 460 - 462. [Full Text] [PDF]

				B. S. Pickard, H. M. Knight, R. S. Hamilton, D. C. Soares, R. Walker, J. K. F. Boyd, J. Machell, A. Maclean, K. A. McGhee, A. Condie, et al. A common variant in the 3'UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorder PNAS, September 30, 2008; 105(39): 14940 - 14945. [Abstract] [Full Text] [PDF]

				P. Clayton and T. Auster Strategies for the Prevention and Treatment of Suicidal Behavior Focus, January 1, 2008; 6(1): 15 - 21. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us